AccessibilityHelpAbout Us
Nanalysis Scientific logo

Nanalysis Scientific(OTC) NSCIF

Market Cap$12.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-76%
5 Year-90%
1 Year-37%
1 Month+3%
$0.09
+0.00%
+0.00Today
Nanalysis Scientific last closing stock price
MetricPriceDate
Last closeUSD 0.092026-09-10
Nanalysis Scientific stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+8.13%USD 0.082026-09-03
1 month+3.34%USD 0.092026-08-10
3 month-2.63%USD 0.092026-06-09
Year to date-18.73%USD 0.112025-12-29
1 year-37.28%USD 0.152025-09-10
3 year-75.3%USD 0.372023-09-11
5 year-90.42%USD 0.952021-09-10
Since inception-76.47%USD 0.392020-04-16

Nanalysis Scientific Financials at a Glance

Market Cap

$12.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$40.38M

Net Income (TTM)

-CA$4.18M

EPS (TTM)

-$0.02

P/E Ratio

-3.84

Dividend

$0.00

Beta (Volatility)

0.18 (Low)

Price

$0.09

Volume

75,000

Open

$0.09

Previous Close

$0.09

Daily Range

$0.09 - $0.09

52-Week Range

$0.08 - $0.16

Estimated Earnings Date

Nov 23, 2026

NSCIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanalysis Scientific

Nanalysis Scientific Corp. develops and manufactures advanced magnetic resonance technology products for various industries globally. The company operates in two segments: Scientific Equipment and Security Services, providing innovative solutions for both scientific and security applications.

Products and Services
  • Nuclear magnetic resonance (NMR) spectrometers for scientific research
  • Software platforms for data acquisition and analysis in magnetic resonance
  • Security services including maintenance and installation of detection equipment
Growth Outlook
  • Recent quarterly revenue of CAD 9.73 million shows strong market demand
  • Year-over-year revenue growth indicates expanding customer base
  • Investment in R&D supports future product innovation and market expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of CAD 39.5 million reflects solid performance
  • Operating cash flow of CAD 639,276 in the latest quarter demonstrates operational efficiency
  • Current ratio of 1.03 indicates adequate short-term financial health
Nanalysis Scientific Corp. is positioned in the healthcare sector, focusing on medical specialties. The company’s innovative products cater to diverse industries, including pharmaceuticals, biotechnology, and security. Recent financial performance highlights a robust revenue stream, with a notable increase in quarterly revenue, suggesting a positive trajectory in market demand. The investment in research and development is expected to drive future growth, enhancing the company's competitive edge. The financial metrics indicate a stable operational foundation, with a current ratio that suggests the ability to meet short-term obligations. Overall, Nanalysis Scientific Corp. presents a compelling opportunity for investors interested in the healthcare technology sector.
AI Generated • Sep 12, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

240

CEO

Sean Krakiwsky

Website

www.nanalysis.com

Headquarters

Calgary, AB T2E 7C3, CA

NSCIF Financials

Key Financial Metrics (TTM)

Gross Margin

20.27%

Operating Margin

-5.03%

Net Income Margin

-10.35%

Return on Equity

-33.44%

Return on Capital

-12.15%

Return on Assets

-12.43%

Earnings Yield

-26.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

139.41M

Volume

75.00K

Avg. Volume

5.33K

Financials (TTM)

Gross Profit

CA$8.19M

Operating Income

-CA$2.03M

EBITDA

CA$515.29K

Operating Cash Flow

CA$2.68M

Capital Expenditure

-CA$909.10K

Free Cash Flow

CA$1.77M

Cash & ST Invst.

CA$540.23K

Total Debt

CA$13.97M

Nanalysis Scientific Performance Analysis

Nanalysis Scientific annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CAD 19,065,89449.0%
20232023-12-31CAD 21,090,81610.6%
20242024-12-31CAD 33,208,96057.5%
20252025-12-31CAD 28,720,624-13.5%
Nanalysis Scientific sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3.0%
Q42025-12-3115.0%
Q12026-03-310.2%
Q22026-06-30-9.1%
Nanalysis Scientific annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CAD -0.08276.1%
20232023-12-31CAD -0.1260.1%
20242024-12-31CAD -0.09-25.8%
20252025-12-31CAD -0.04-60.7%
Nanalysis Scientific sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3034.5%
Q42025-12-3158.0%
Q12026-03-31-72.7%
Q22026-06-3049.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CA$9.73M

+1.6%

Gross Profit

CA$1.71M

-26.6%

Gross Margin

17.54%

N/A

Market Cap

$12.68MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$828.70

N/A

Employees

15,299

N/A

Net Income

-CA$666.29K

+68.6%

EBITDA

CA$598.26K

+175.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CA$540.23K

+57.0%

Total Debt

CA$13.97M

-20.8%

Accounts Receivable

CA$8.35M

-4.4%

Inventory

CA$4.22M

-5.2%

Long Term Debt

CA$6.94M

+1.2%

Short Term Debt

CA$7.02M

-34.8%

Return on Assets

-12.43%

N/A

Return on Invested Capital

-10.20%

N/A

Free Cash Flow

CA$625.27K

+131.2%

Operating Cash Flow

CA$639.28K

+140.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BNSOFBonso Electronics International Inc.
$2.18+0.00%
YNVYFYnvisible Interactive Inc.
$0.06+0.00%
ROBOFRoboGroup T.E.K. Ltd.
$0.14+0.00%
SDCHSideChannel, Inc.
$1.56-1.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$44.99-10.22%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$114.82+10.44%
INTCIntel
$108.80+7.67%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.53-5.12%

Questions About NSCIF

What is the current price of Nanalysis Scientific?

Nanalysis Scientific is trading at $0.09 per share.

What is the 52-week range for Nanalysis Scientific?

Over the past 52 weeks, Nanalysis Scientific has traded between $0.08 and $0.16.

How much debt does Nanalysis Scientific have?

As of the most recent reporting period, Nanalysis Scientific reported total debt of CA$9.84M.

How much cash does Nanalysis Scientific have on hand?

Nanalysis Scientific reported CA$380.62K in cash and cash equivalents in its most recent financial results.

What is Nanalysis Scientific’s dividend yield?

Nanalysis Scientific does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services